1,089 research outputs found

    The Impact of IS-Business Alignment Practices on Organizational Choice of IS-Business Alignment Strategies

    Get PDF
    This study utilizes a mixed method approach to examine the relationship between IS/Business alignment practices and organizational choice of IS/business alignment strategy. To this end, the significance of six maturity factors of IS/Business alignment – governance, partnership, scope and architecture, communication, value, and skills – from the Strategic Alignment Maturity model are examined against three alignment strategies (independent, sequential, and synchronous) adopted by different organizations. Governance and partnership were found to be the most significant factors towards the evolutive process of IS/business alignment regardless of the alignment strategy. Moreover, our data shows that organizations that are most mature in partnership have a higher tendency to implement sequential integration strategy (IS strategy formulation follows and supports business strategy formulation) and not synchronous – where IS strategy formulation and business strategy formulation are done simultaneously. Follow-up group discussions with senior managers were also conducted in an attempt to identify the top management practices that advance the IS/business alignment process. The discussions revealed three management practices that considerably contribute to the process of aligning IS and business strategies: (1) the formalization of a program management process, (2) the improvement of support for hierarchies of authority, and (3) the integration of collaboration values. Those findings are discussed and future avenues of research are offered

    Investigating the situated culture of multi-channel customer management:A case study in Egypt

    Get PDF
    This paper investigates the influence of national culture on customers' behavior and customers' choice of channel through the customer life cycle stages. An exploratory in-depth single case study in a multinational organization in Egypt was conducted. Specifically, 31 in-depth interviews were conducted with members of staff in marketing, IT, retail and customer services departments, and external prospects/customers. Based on an interpretive approach, the authors have articulated a situated cultural approach based on structuration theory to identify the cultural dimensions that have provided an understanding of the cultural influence on customers' channel choice. The results highlighted that verbal, human interaction, traditional shopping, and cash based were the themes for customers' channel choice through the four stages of customer life cycle. The results also show that the customers' channel choices were linked to the following Egyptian cultural dimensions: collectivism, market price relationship, emotional, power distance, low trust, uncertainty avoidance, and universalism

    Overcoming Melanoma Immune Tolerance: Non-specific CTLA-4 Blockade/Interferon-alfa and Antigen Specific Immunization with TLR-9 Stimulation/Local GM-CSF as Components of a Melanoma Immunotherapeutic Strategy and Associated Biomarkers of Therapeutic Benefit

    Get PDF
    Immunotherapy utilizing cytokines or immune regulatory check point blockade has consistently demonstrated superior clinical efficacy in melanoma when compared to tumor peptide immunization strategies reported to date. In this project, I conducted 2 model studies representing alternative immunotherapeutic approaches (non-antigen specific combination of interferon-á2b and an anti-CTLA4 monoclonal antibody, IFN-Treme compared to a tumor antigen specific multi-epitope vaccine given in adjuvant with the potent combination of a TLR-9 agonist and GM-CSF) designed to overcome tumor immune evasion and conducted separately in a similar patient population. In addition to evaluating safety and clinical efficacy, I tested the following hypotheses: (1) Clinical benefits are likely to be associated with markers of reversal of immune tolerance (autoimmunity). (2) Clinical benefits may be predicted by baseline peripheral biomarkers of immune tolerance/suppression (C-reactive protein, CRP and absolute lymphocyte count, ALC). (3) Superior antitumor efficacy is likely to be associated with more effective downregulation of the host suppressor immune response (circulating T regulatory cells, T-reg and myeloid derived suppressor cells, MDSC). My findings supported superior clinical efficacy that was associated with more significant modulation of immune tolerance by the combination of IFN-Treme. Autoimmunity correlated with improved clinical outcome among the recipients of IFN-Treme (but not the vaccine) and suggested more significant reversal of immune tolerance. Baseline CRP and ALC were significantly predictive of therapeutic benefit with the IFN-Treme combination and may serve as variables for stratification of future trials, as these are validated in larger studies. Finally, my findings supported more significant downregulation of the host suppressor immune response by the nonspecific IFN-á/Treme regimen as compared to the vaccine-TLR agonist/GM-CSF combination. There was apparent increase in CD4+CD25hi+ CD39+ Treg but this was associated with an increase in the overall CD4+ T cell population suggesting that direct inhibition of CTLA4 suppressive effects on T effector cells leading to their expansion and prolonged activation is likely more important than the regimen's effect on T-reg. In addition, I saw parallel downregulation in several populations of MDSC following treatment with IFN-Treme which may have had a role in the reduction of immune suppression and superior clinical outcome observed
    • …
    corecore